Novozymes A/S
NVZMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $28,085,495 | $210,039,190 | $185,627,458 | $180,351,672 |
| - Cash | $329,245 | $328,200 | $249,500 | $280,000 |
| + Debt | $3,637,259 | $3,321,700 | $1,699,000 | $1,796,800 |
| Enterprise Value | $31,393,510 | $213,032,690 | $187,076,958 | $181,868,472 |
| Revenue | $1,246,234 | $7,598,058 | $8,043,072 | $7,464,673 |
| % Growth | -83.6% | -5.5% | 7.7% | – |
| Gross Profit | $636,634 | $4,061,996 | $4,435,781 | $4,573,222 |
| % Margin | 51.1% | 53.5% | 55.2% | 61.3% |
| EBITDA | $389,236 | $2,658,761 | $3,081,088 | $2,755,903 |
| % Margin | 31.2% | 35% | 38.3% | 36.9% |
| Net Income | $161,499 | $1,020,534 | $1,388,281 | $902,040 |
| % Margin | 13% | 13.4% | 17.3% | 12.1% |
| EPS Diluted | 0.35 | 0.29 | 0.4 | 0.53 |
| % Growth | 20.7% | -27.5% | -24.5% | – |
| Operating Cash Flow | $546,210 | $320,100 | $106,400 | $491,800 |
| Capital Expenditures | -$111,517 | -$82,200 | -$55,200 | -$212,100 |
| Free Cash Flow | $434,694 | $237,900 | $51,200 | $279,700 |